
Could we see an end to severe health and mental issues over the next decade? According to Anthropic (ANT) CEO Dario Amodei, it’s possible, thanks to artificial intelligence. In fact, as quoted by Seeking Alpha, he said, “If today we look at things like cancer, Alzheimer's, heart disease, mental illness, these will be relics of the past in, I think, less than a decade.”
That's quite the claim about the power of AI to forever change the face of medicine. And it’s easy to see why it got attention. For anyone who has watched a loved one go through treatment, even a few years of faster progress in their overall medical or mental health would matter immensely.
Presently, Anthropic is testing how AI can help at several points in drug development. In October, it described work with companies including BigHat Biosciences, Generate Biomedicines (GENB), Divergence Labs, and Bristol Myers Squibb (BMY). The projects range from improving experimental drug candidates to planning early clinical studies.
As noted by Anthropic's website:
Imagine a research team trying to decide which of thousands of possible compounds to test first. AI can help rank the candidates, giving researchers a smaller list to take into the lab. That could save time at a stage where scientists often have more ideas than they have the resources to pursue. Then, researchers need to find out which doses people can tolerate, whether benefits last, and whether side effects emerge as more people take a drug. An AI model can help researchers choose what to test next. However, some of the most important answers still come from following patients over time.
Or, look at mental health issues. Consider two people diagnosed with depression. One may struggle to sleep, while the other can barely get out of bed. They may also respond differently to the same treatment. AI could help researchers search for patterns in who responds to a particular therapy or medication. If those patterns hold up in real clinics, they could help patients spend less time trying treatments that bring little relief.
Ten years from now, the numbers worth checking will be how many people avoided a late-stage cancer diagnosis, how many lived longer after treatment, and how many got lasting relief from depression. If AI helps move those numbers in the right direction, it will have changed medicine in ways patients can feel.
Anthropic will start trading on the Nasdaq under the ticker symbol ANT on Thursday, Nov. 19, 2026.